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Abstract 12 
White spot syndrome virus (WSSV) is the most catastrophic pathogen the shrimp 13 
industry has ever encountered. VP28, the abundant envelope protein of WSSV was expressed 14 
in bacteria, the purified protein administered orally to Penaeus monodon juveniles and its 15 
immune modulatory effects examined. The results indicated significant up-regulation of 16 
caspase, penaeidin, crustin, astakine, syntenin, PmRACK, Rab7, STAT and C-type lectin in 17 
animals orally administered with this antigen. This revealed the immune modulations in 18 
shrimps followed by oral administration of rVP28P which resulted in the reduced 19 
transcription of viral gene vp28 and delay in mortality after WSSV challenge. The study 20 
suggests the potential of rVP28P to elicit a non-specific immune stimulation in shrimps. 21 
1. Introduction  22 
Penaeid shrimp, one of the most economically important crustaceans, faces significant 23 
outbreaks of many diseases that have damaged aquaculture. White spot syndrome virus 24 
(WSSV) is the most catastrophic pathogen the shrimp industry has ever encountered [1,2]. 25 
Since the first report of WSSV in 1993, the major concern of world aquaculture industry has 26 
been to stave off this disease emerging in aquaculture settings [3]. There is increasing 27 
evidence based on laboratory trials that the administration of antigens or immunostimulants is 28 
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a promising approach to stimulate shrimp immune system against viral or bacterial infections. 29 
Administration of inactivated whole virus, oral recombinant protein antigens and DNA and 30 
dsRNA molecules provides remarkable protection to shrimp from WSSV as reviewed by 31 
Rowley and Pope [4] and Haq et al. [5].  32 
Several investigations suggest that the administration of recombinant WSSV proteins, 33 
particularly VP28, imparts a form of immune stimulation, described as immune priming, 34 
resulting in increased survival of shrimps in subsequent virus infections [6]. VP28 is the 35 
major envelope protein of WSSV that expedites entry of the virion into shrimp cells [7]. The 36 
mRNA transcription of WSSV genes was delayed for 4~10 days in various organs of shrimp 37 
vaccinated with recombinant VP28 (rVP28) [8].  However, the underlying mechanism by 38 
which rVP28 activates the shrimp defense system remains unknown. 39 
The crustacean immune system eliminates pathogens very efficiently through humoral 40 
and cellular immune processes. The biological defense molecules produced in shrimps in 41 
response to the invading pathogens include proteins and peptides related to immunity, 42 
homeostasis, host pathogen interaction and other cellular processes. Identification and 43 
functional analysis of immune related genes such as AMPs, proteinases and their inhibitors, 44 
anti-apoptotic proteins, pattern recognition receptors (PRRs) revealed its specific roles in 45 
shrimp defense system and in disease process [9].  Shrimps evolved to use diverse 46 
antimicrobial peptides (AMPs) and proteins with diversity in structure and function as the 47 
first-line of innate immune response [10]. The identification of thousands of high quality 48 
Expressed Sequence Tags (EST) in shrimps suggested that WSSV infection modulates the 49 
genes involved in several cellular and metabolic immune processes in post larvae [11]. 50 
Administration of immune stimulants alters the expression of wide range of cellular and 51 
immune related genes and triggers the innate immune reactions in shrimps by upregulation of 52 
penaeidin, lysozyme, crustin and JAK-STAT pathway genes and downregulation of AMPs 53 
and clotting related proteins in WSSV resistant animals [12,13]. 54 
The high frequency of occurrence and differential expression of immune-related 55 
genes in shrimps infected with WSSV, Vibrio harveyi or administered with probiotics further 56 
emphasize the molecular changes during an elevated immune response [14,15]. Earlier 57 
reports also demonstrated enhanced expression of few immune-related genes upon VP28 58 
based DNA vaccination [16,17]. However, immune modulations at molecular level upon 59 
VP28 administration in shrimps [6] is scanty, which point to the relevance of the present 60 
study. Genes associated with immune functions such as pathogen recognition, clotting, 61 
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melanisation, agglutination, apoptosis, proPO pathway and signal transduction are 62 
characterized in shrimps. In the present study, expression of genes associated with these 63 
immune processes such as caspase, penaeidin, crustin, astakine, syntenin, P. monodon 64 
activated protein kinase C (PmRACK), Rab7 receptor, signal transducer and activator of 65 
transcription (STAT), superoxide dismutase (SOD), toll like receptor (TLR) and C-type lectin 66 
are assessed. We investigated the immune modulation in P. monodon juveniles (PL 40) after 67 
oral administration of rVP28P and assessed the survival rate of animals challenged with 68 
WSSV.  69 
2. Materials and Methods 70 
2.1 Expression and purification of WSSV VP28 from Indian WSSV isolate 71 
 The VP28 gene (vp28) identified from an Indian WSSV isolate was retrieved from 72 
Genbank (AY422228.1), and putative trans-membrane regions of VP28 were predicted by 73 
using TMpred (http://www.ch.embnet.org/software/TMPRED_form.html) (Data not shown). 74 
Expression construct of VP28 was generated in fusion with His6X tag. The full length ORF 75 
of 612 bp (VP28) and a truncated form of 546 bp (VP28P) without N-terminal 76 
transmembrane region (amino acids 1-22) were PCR amplified. Gene specific primers 77 
carrying BamHI and NotI restriction sites were used for the amplification of the insert 78 
sequences from TOPO vector and cloned into pET28a+ expression vector (Novagen, 79 
Madison, Wisconsin, USA).  Transformation and expression of rVP28 and rVP28P were 80 
achieved in E. coli BL21 (Invitrogen, Carlsbud, MA, USA). Their over expression in E. coli 81 
was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 82 
and western blot using 6X Histidine specific monoclonal antibody (1:20000; Genei, 83 
Banglore, India). 84 
  The rVP28 and rVP28P expressed E. coli BL21 cultures were re-suspended in binding 85 
buffer (50 mM NaH2PO4, 20 mM Tris, 100 mM NaCl) and sonicated.  As the full length 86 
rVP28 accumulated as inclusion bodies, rVP28P available in the soluble form was selected 87 
for further purification by immobilized metal affinity chromatography (IMAC). The total cell 88 
lysate was loaded onto Ni-Sepharose column and gradient elution was carried out by adding 89 
imidazole at concentrations of 50–500 mM after incubation for 3 hr. The purified rVP28P 90 
was concentrated by ultrafiltration (Amicon Ultra 15, Millipore, MA, USA), dialyzed and, 91 
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assessed for the presence of bacterial endo-toxin using Limulus Amebocyte Lysate (LAL) 92 
assay as per manufacturer’s (E-Toxate Kit, Sigma, St. Louis, MO, USA) protocol.  93 
2.2 Oral administration of rVP28P to P. monodon juveniles and WSSV challenge 94 
2.2.1 Experimental animals  95 
  Specific Pathogen Free (SPF) P. monodon juveniles (PL 40) maintained in a 96 
recirculating aquaculture system developed by National Centre for Aquatic Animal Health, 97 
Cochin University of Science and Technology, Cochin, Kerala, India was used for the study.  98 
The WSSV-free status of animals was tested by nested PCR as described by Lo et al. [18] 99 
using viral DNA extracted from whole animal. The shrimps were transferred to rectangular 100 
fiber reinforced plastic (FRP) tanks of 30 litre capacity prior to the experiment and 101 
acclimatized to 20 g L-1 salinity filtered sea water at 28 ± 1 ○C, having total ammonia < 0.1 102 
ppm, alkalinity 70-80 ppm at pH 8.4, for one week. The animals were maintained at this 103 
optimum conditions through partial exchange of water whenever required. During this period, 104 
shrimps were fed with a commercial feed (Amalgam Nutrients and Feeds Limited, Cochin, 105 
India) at the rate of 10% body weight per day. 106 
2.2.2 Preparation of rVP28P protein coated feed 107 
rVP28P was produced in large scale and a quantity of 100 µg purified rVP28P 108 
blended with 1ml phosphate buffered saline (PBS-pH 7.4). This was mixed with 4 g (at the 109 
rate of 25 µg protein g -1 feed) commercial shrimp feed pellets (Amalgam Nutrients and 110 
Feeds Limited, Cochin, India) and incubated overnight at 4 ○C to allow the absorption of 111 
protein. The pellets were further coated with a commercial binder (Trubind, Wockhardt, 112 
Mumbai, India) to prevent dispersion of the protein in water and maintained at 4 ○C. 113 
Similarly, control feed was prepared by soaking in PBS and coating with the same 114 
commercial binder.  115 
2.2.3 Oral administration of rVP28P and WSSV challenge 116 
Four groups of animals (groups of 125) each animal weighing 2-4 g were used for the 117 
experiment and the design was as shown in Table 1. Feed mixed with PBS alone was 118 
administered to two batches of animals (PBS 1 and PBS 2) and maintained as controls and 119 
two batches administered with rVP28P in PBS (rVP28P 1 and rVP28P 2) served as the tests. 120 
All the animals were starved for 6 hr and offered PBS and rVP28P dissolved in PBS as 121 
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control and test feeds respectively. The feeding rate was of 10% of the body weight twice a 122 
day for a period of ten days and thereafter, resorted to normal commercial feed. On 1st day 123 
post administration of the coated feed, a batch of rVP28P (rVP28P 2) and PBS administered 124 
(PBS 2) animals were challenged with WSSV by feeding freshly infected tissue (soft tissue 125 
from cephalothorax confirmed WSSV positive through nested PCR) at a rate 10% of the body 126 
weight [19]. The uneaten WSSV infected tissue pieces were removed from the tanks after 4 127 
hours of feeding along with complete replacement of water with fresh sea water. The 128 
percentage survival of the rVP28P administered animals at the event of challenge with WSSV 129 
compared with that in the control group was recorded. 130 
2.3 Tissue sampling, RNA extraction and cDNA synthesis 131 
Animals survived were collected from unchallenged and WSSV challenged groups on 132 
2nd, 5th and 8th days post administration (dpa) and post challenge (dpc) respectively. Three 133 
batches of animals comprising three animals each from each group were collected from tests 134 
and controls, euthanized by immersing in ice flakes, washed with diethyl pyrocarbonate 135 
(DEPC) treated water, preserved in Tri- Reagent (Sigma, USA) and maintained at -80 ○C.  136 
Total RNA was extracted individually from each whole animal of all experimental groups and 137 
converted to cDNA within 12 hr of collection of samples under RNase free condition. The 138 
total RNA was isolated using TRI reagent (Sigma, St. Louis, MO, USA) following 139 
manufacturer’s protocol with slight modifications. Briefly, the samples were homogenized 140 
and 200 µL chloroform was added per ml of TRI reagent. The RNA was precipitated with 141 
70% isopropyl alcohol, dissolved in 20 µL RNase free water followed by DNase I treatment 142 
at 37 ○C. Further, the quality and quantity of RNA was determined using UV–visible 143 
spectrophotometer and confirmed using Qubit RNA assay kit (Life technologies, USA). RNA 144 
was subjected to electrophoresis on denaturing gel (5% polyacrylamide gel in Tris -borate 145 
EDTA (TBE buffer) containing 7 M urea) to assess the integrity of RNA. Immediately after 146 
RNA extraction, 5 µg RNA was reverse transcribed to cDNA using Moloney Murine 147 
Leukemia Virus (M-MuLV) Reverse Transcriptase and oligo dT(12-18) (New England Biolabs, 148 
MA, USA) as per the standard protocol and the quality and quantity of cDNA were also 149 
assessed spectrophotometrically. 150 
2.4 Expression of immune-related genes upon rVP28P administration - semi 151 
quantitative reverse transcriptase - polymerase chain reaction (RT-PCR)    152 
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 All extracted RNA samples had Abs260/Abs280 ratio of 1.8-2.0 in water and were used 153 
for cDNA preparation from 5 µg of total RNA. The 25 µL PCR mixture with 200 µM dNTPs, 154 
10 pmol each forward and reverse primers, 1 X PCR buffer (Thermopol), 0.5 U Taq DNA 155 
Polymerase and 1 µL cDNA each were used. The cycle parameters were initial denaturation 156 
at 94 ºC for 5 min, 25-30 cycles of 94 ºC for 30 s, annealing for 30 s, extension for 1 min at 157 
72 ºC and a final extension at 72 ºC for 10 min. The PCR cycles and the cDNA dilution had 158 
been optimized so that the target gene and reference gene amplification could be obtained at 159 
logarithmic phase. In order to check the consistency, the reactions were repeated three times 160 
for each gene per sample. The target gene, predicted amplicon size, cycling conditions and 161 
primer sequences for each target gene and its source are presented in Table 2. 162 
 Shrimp elongation factor-5A (EF-5A) was used as the reference gene based on its 163 
consistency in the previous experiments. The PCR products were analyzed by horizontal gel 164 
electrophoresis and the average integrated density values (IDV) of the amplicons were semi-165 
quantitatively measured using Quantity One® software (Bio-Rad, Philadelphia, USA) and 166 
normalized with the expression of EF-5A.  167 
2.5 Statistics 168 
Statistical analyses were performed using GraphPad Prism 6 (GraphPad Software 169 
Inc., San Diego, USA). The amplification plots were constructed and represented as mean ± 170 
standard deviation of the IDV. Differences between the gene expression of the unvaccinated 171 
and rVP28P vaccinated animals at three time points were calculated using non-parametric t-172 
test having p ≤ 0.05 considered significant. Mean values of target gene expression in three 173 
samples, normalized with the expression of the reference gene EF-5A are presented. 174 
3. Results 175 
3.1 Expression and purification of rVP28P 176 
The WSSV vp28 gene was cloned and expressed in E. coli BL21. The VP28 protein 177 
sequence contained N-terminus hydrophobic membrane anchoring domain at amino acids 1-178 
22, as elucidated by TMpred (Data not shown). The full length ORF rVP28 (612bp) and a 179 
partial reading frame VP28P (546 bp) were expressed in bacteria using pET28a expression 180 
system. Bands corresponding to 27 kDa and 25 kDa of full length and truncated protein 181 
respectively were visualized in an SDS-PAGE stained with Coomassie Blue G-250 (Fig.1a). 182 
The truncated rVP28P expressed in large quantity as soluble protein was further purified 183 
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using Ni-NTA affinity chromatography, and eluted in 250 mM imidazole (Fig.1b). The 184 
purified and dialyzed rVP28P exhibited reactivity with antibodies to His6X (Fig.2a). The 185 
endotoxin level in the purified rVP28P was negligible (<1pg/ml of lipopolysaccharide) as 186 
determined by LAL assay. 187 
  3.2 Oral administration of rVP28P and WSSV challenge 188 
The animals used in the study had been confirmed WSSV free through two step 189 
nested PCR for virus detection prior to the experiment. The rVP28P administered and 190 
unchallenged animals did not show any sign of infection. Expression of vp28 was 191 
significantly low in rVP28P administered animals on 2nd and 8th dpc compared to the control 192 
group (Fig.2b). The reduced expression of vp28 indirectly evidenced the low proliferation of 193 
WSSV in the rVP28P administered shrimps.  194 
3.3 Expression of immune-genes in shrimps administered with rVP28P 195 
            Shrimps were orally administered with rVP28P for 10 days and expression of selected 196 
immune genes assayed, which indicated the effect of this antigen in the immune system. The 197 
statistically significant (p <0.05) up and down regulations when compared with the PBS 198 
control group at each time point alone have been brought under this section. Accordingly, 199 
caspase transcripts were found up-regulated in the rVP28P administered animals on 2nd dpa. 200 
However, it was low in both administered and non-administered groups on 5th and 8th dpa.  201 
(Fig.3a). Crustin was up- regulated in the rVP28P administered group on 8th dpa (Fig. 3b). 202 
Expression of penaeidin was high on 2nd dpa without any variations on other two time points, 203 
as shown in Fig. 3c. Peneidin transcripts were up regulated in rVP28P administered group on 204 
2nd dpa compared with that of the control group (Fig. 3c). Astakine was up regulated on 8th 205 
day in the rVP28P administered group (Fig. 3d).  Up regulation of syntenin on 5th and 8th dpa 206 
in the rVP28P administered groups is shown in Figs 3e. A significant upregulation of 207 
PmRACK was noticed on 2nd dpa. PmRab7 transcripts were up-regulated on 5th and 8th dpa (p 208 
<0.05) (Fig. 4a). STAT expression was high on 8th dpa (Fig. 4b). Low level expression of 209 
TLR was observed on 8th dpa compared with that of the control (Fig. 4c).  C-type lectin 210 
exhibited up-regulation on 8th dpa in the rVP28P administered animals (Fig. 4d) with no 211 
variation between administered and control groups at any time points.  212 
Among the seven immune-related genes analyzed, caspase, penaeidin, crustin, 213 
astakine, syntenin, PmRACK, Rab7, STAT and C-type lectin transcripts exhibited up-214 
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regulation after rVP28P administration at least at one-time point, whereas TLR was down-215 
regulated.  216 
3.4 Time - mortality relationship of animals after rVP28P administration and WSSV 217 
challenge 218 
In the survival analysis, rVP28P administered animals exhibited delayed mortality 219 
compared to the PBS administered group (positive) which exhibited 100% mortality on 10th 220 
dpc. The unchallenged animals (negative) exhibited no mortality (Fig. 5). 221 
4. Discussion 222 
In the present study, we conducted an investigation of the gene expression pattern in 223 
the rVP28P immunized shrimps using the whole animal (P. monodon juveniles) instead of 224 
specific shrimp tissue or organ. WSSV is systemic and infects ectodermal and mesodermal 225 
originated tissues and organs of shrimps and the immune response vary among different 226 
tissues and organs [20]. In different cell types, the virus is likely to modulate the gene 227 
expression differently in order to promote its multiplication. Therefore, the assessment of 228 
immune molecules in whole animal reveals the overall molecular changes which might be 229 
underlying rVP28P mediated protective immunity in shrimps.  230 
E. coli based protein expression system yields the highest quantity of rVP28P from a 231 
given biomass. The expression analysis of full-length and truncated VP28 in E. coli indicates 232 
higher level of soluble expression of the latter while the former accumulated as inclusion 233 
bodies. The high yield and solubility of rVP28P aids large scale production for commercial 234 
purposes, and may enhance the bioavailability and absorption of the protein in the gut of the 235 
animal after oral administration. The high solubility of rVP28P also facilitates its purification 236 
in non-denaturant condition.   237 
Despite several reports demonstrating the efficacy of crude rVP28 against WSSV [6], 238 
we used purified rVP28P, which was tested endotoxin-free. This facilitated the assessment of 239 
immune responses highly specific to the WSSV antigen VP28.  240 
The expression of WSSV gene vp28 transcripts correlated   with the WSSV 241 
proliferation and immune-related gene expression indirectly. Transcriptional analysis of 242 
WSSV genes, particularly vp28, is a well-known approach to assess the viral replication after 243 
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rVP28 administration [8]. Silencing studies of vp28 gene further demonstrated its vital role in 244 
WSSV replication [21].  245 
The expression of caspase in rVP28P administered shrimps was upregulated on the 246 
2nd dpa compared with PBS control. This may indicate the immediate activation of caspase 247 
by the oral administration of rVP28P. Suppression of caspase gene in M. japonicas prior to 248 
WSSV invasion led to inhibition of apoptosis and increase in WSSV copy number [22]. The 249 
role of caspase in anti-WSSV immunity is also evident from the high expression of caspase in 250 
shrimps infected with WSSV [23, 24]. In the present study, the high level expression of 251 
caspase only on 2nd dpa indicates that the antigen administration needs further optimization to 252 
maintain the enhanced expression in the rVP28P administered animals to provide prolonged 253 
protection. The enhanced and prolonged caspase expression through rVP28P vaccination may 254 
help the animals to resist subsequent WSSV infections.  255 
The significant upregulation of crustin on 5th and 8th dpa in vaccinated animals when 256 
compared with the PBS control group indicates the efficacy of rVP28P as a candidate 257 
antigen to stimulate immune system. This can be further correlated with the reduced viral 258 
load in the vaccinated animals as evidenced from the low gene expression of vp28. Crustin-259 
like AMPs were found to be constitutively expressed in shrimps and upregulated after the 260 
administration of immune stimulants and WSSV challenge [25]. The significant increase of 261 
crustin in the vaccinated animals indicates the effect of rVP28P vaccination in the shrimp 262 
immune system by increasing the expression of AMPs. 263 
The recombinant vaccine administration significantly enhanced the expression of 264 
penaeidin on 2nd dpa. This peptide is constitutively synthesized and released into plasma after 265 
microbial challenge [26] and, upregulated during Vibrio infection in post larvae [27]. These 266 
studies demonstrated its role in shrimp host defense and rVP28P mediated protective 267 
immunity.  268 
In crayfish, Pacifastacus leniusculus, hematopoiesis is regulated by an invertebrate 269 
cytokine astakine, critical for hemocyte count [28]. The enhanced expression of astakine after 270 
rVP28P vaccination in the test animals can positively elevate the hemocyte count and 271 
improve the immune status. The high levels of astakine may also contribute to the low 272 
expression of vp28 in the vaccinated animals after WSSV challenge.  273 
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Syntenin is an adaptor protein that links various molecules in signal transduction 274 
pathway.  Previous studies reported enhanced expression of syntenin in WSSV infected 275 
shrimps which declined rapidly as the infection progressed. This implied the role of syntenin 276 
as an important molecule in shrimp immune response subsequent to viral infection [29]. In 277 
the present study syntenin levels were significantly higher in rVP28P administered animals 278 
on 5th and 8th days after rVP28P administration. The stable maintenance of high levels of 279 
syntenin in the animals could attribute to the reduced severity of infection and may offer 280 
protection against subsequent viral attacks.  281 
PmRACK-1 was elevated in the rVP28P administered animals at all the three time 282 
points compared with its PBS control with a significant upregulation on 2nd dpa. This kinase 283 
receptor interacts with the VP9 viral protein of WSSV and involves in the response against 284 
viral infection in P. monodon [30]. It can also participate in the shrimp antioxidant response 285 
induced by the formation of ROS [31]. This postulates the rVP28P binding mediated signal 286 
transduction activation of the kinase receptor and its role in vaccination mediated protective 287 
immunity in shrimps.  288 
Rab7 is a VP28 binding protein that aids the recognition and entry of WSSV into 289 
shrimp cells. The real-time PCR analysis demonstrated that PmRab7 transcripts were 290 
constitutively expressed during the course of WSSV infection and PmRab7-VP28 binding 291 
reduces the severity of infection [32]. The enhanced expression of Rab7 on 5th and 8th dpa in 292 
the rVP28P vaccinated shrimps implies that rVP28P immunization may aid the neutralization 293 
of WSSV in the future viral exposures through Rab7-VP28 interaction and successive 294 
immune activation.   295 
The significantly increased expression of STAT gene on 8th dpa may help the immune 296 
system to respond to a later infection through some unknown STAT-mediated immune 297 
mechanism. WSSV uses shrimp STAT as transcription factor to enhance viral gene expression 298 
[33]. Here, an increase in STAT gene expression correlates with reduced copies of vp28 299 
transcripts after WSSV challenge. The STAT-mediated immune activation may reduce the 300 
expression of vp28 and other viral genes thus, negatively affect the WSSV establishment.  301 
The innate immune system of shrimps recognizes and binds to specific patterns on the 302 
surfaces of pathogens through PRRs [34] and this recognition mechanism and clearance of 303 
the pathogen is the supreme part of the shrimp innate immune system. TLR is an important 304 
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PRR in shrimps that recognize molecules derived from microbes [35]. Down-regulation of 305 
TLR in the rVP28P administered animals on 8th dpa evidences to the low significance of TLR 306 
mediated immune recognition in this context. C-type lectin is also a major PRR in shrimps 307 
and its reduction increases mortality of shrimps during WSSV infection [36]. The significant 308 
up-regulation on 8th dpa with rVP28P vaccination may help the animals to resist virus 309 
establishment in the future exposures.  310 
Time - mortality relationship of shrimps after rVP28P administration and WSSV 311 
challenge demonstrated delayed mortality of animals administered with rVP28P. Earlier 312 
reports demonstrated the efficacy of VP28 as an oral vaccine which offered more than 60% 313 
survival in administered animals [37,38].  In the present study, the oral administration of 314 
rVP28P did not show similar trend in survival, except a delay in mortality when compared to 315 
that of the controls. More investigations are required to delineate the situation.   316 
The present study suggested significant up-regulation of caspase, penaeidin, crustin, 317 
astakine, syntenin, PmRACK, Rab7, STAT and C-type lectin in the rVP28P vaccinated 318 
animals. This points out the immunomodulation followed by oral administration of rVP28P in 319 
P. monodon juveniles at molecular level.  This resulted in the low expression of viral gene 320 
vp28 and enhanced resistance of shrimps to WSSV and thereby delayed mortality of animals 321 
in the subsequent viral challenge. These results are supported by our earlier studies on the 322 
modulation of immune-related genes in shrimp juveniles administered with rVP24 [39]. Even 323 
though, shrimps lack adaptive immunity and antibodies, investigations on immune 324 
modulations and the underlying mechanisms involved, can pave way for a better 325 
understanding of how shrimp immune system interacts with pathogen components, 326 
particularly rVP28P.   327 
The study suggests that rVP28P alone may not protect shrimp from WSSV, and a 328 
cocktail of recombinant viral proteins along with immunostimulants might accord protection 329 
by enhanced elicitation of non -specific immune mechanism coupled with management of the 330 
environment favorable to the animal.  The study thus opens up challenging new opportunities 331 
for investigation. 332 
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Table-1 Experimental design for oral administration of rVP28P in P. monodon juveniles with     
timeline of sample collection  
 
 Group       Coating material                       No. of shrimps                     Tissue collection            
  (administered for 10days) Unchallenged   WSSV challenged     
    (1dpa)   
PBS 1 (control)  PBS   3x125      -                       2nd, 5th and 8th dpa* 
PBS 2 (control)  PBS     3x125                  2nd, 5th and 8th dpc# 
rVP28P 1 (test)       PBS+rVP28P  3x125      -                 2nd, 5th and 8th dpa* 
rVP28P 2 (test)       PBS+rVP28P    3x125                  2nd, 5th and 8th dpc# 
dpa - days post administration ; dpc – days post challenge 
* Immune gene expression analysis; # WSSV gene vp28 expression analysis 
 
Table-2 Amplicon size and primers used to amplify WSSV genes and immune-related genes 
Target Amplicon size  Annealing    Primer sequence               Reference/GenBank  
                 (bp)  tem (⁰C)                             Accession Number   
 
EF-5A  737 55 F-5’GCTCTCTCGCTCCTCCTTTCA3’ Loongyai et al.,2007 
    R-5’CCCATGGACAAAGCAAAGG3’ 
vp28  555 55 F-5’CTGCTGTGATTGCTGTATTT3’ Liu et al.,2005                         
R-5’CAGTGCCAGAGTAGGTGAC3’ 
Caspase 827 57 F-5’GGAGGAACCTGCGAAGAA3’        Wongprasert et al.,2007 
R-5’AGCGTCGAGTGGATGTAAG3’   
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Crustin  430 55 F-5’CGCACAGCCGAGAGAAACACT3’  GQ334395.1                                                 
                          R-5’GGCCTATCCCTCAGAACCCA3,       
Penaeidin-3 240  55 F-5’AGGATATCATCCAGTTCCTG3’  JX961662.1                           
                          R-5’ACCTACATCCTTTCCACAAG3’  
Astakine 455 56 F-5’GTCGCGCATTTAACAAGGAG3’  EU980446.1                      
                          R-5’CCCTGTGGATTGAGCTCACT3’    
Syntenin 750 55 F-5’GATTTGGCCGTCTCACA3’   AF335106.1                
R-5’GCCTTAAGTTACAGGTCGG3’      
PmRACK-1 937 60  F-5’CTGCGCGGGACCCTGGTG3’   KF041001.1                                
                       R-5’CACGGGAAGTAACGCTGACCT3’                
Rab7  887 55 F-5’TTCCCTCCCAAAGTACAT3’   DQ231062.1                          
R-5’AGGCCAATCCCCATGTGAA3’ 
STAT  620 55 F-5’AGCCCCTGTCTGAGCGAA3’   EU367985.1                         
R-5’CTGAGGCTTCATGAAGTTGG3’  
TLR  670 56 F-5’CTGAGAAACAACAGTTTG3’   GU014556.1 
    R-5’GCATTTTGAAATCGAGCG 3’      
C-type lectin 546 57  F-5’CGTGGATCCCAACCTCTTCAGG3’   DQ078266.1      
                        R-5’CGTGAATTCAGCATTGTACTG3’ 
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Figure 1 
 
Fig. 1(a) SDS-PAGE of rVP28 and rVP28P expression in E. coli BL21. Lane 1-E. coli BL21 
host induced, Lane 2-pET28a E. coli BL21 induced, Lane 3-VP28P pET28a+ uninduced, Lane 4 
to 5-rVP28P expressed in E. coli BL21, Lane 6- rVP28 expressed in E. coli BL21, Lane 7-
Protein molecular weight marker (kilodaltons). 1(b) SDS-PAGE of the purified rVP28P by 
immobilised metal affinity chromatography. Lane 1-Protein molecular weight marker 
(kilodaltons), Lane 2-Flow through fraction containing the unbound proteins, Lane 3-Wash 
fraction that removes all unbound proteins, Lane 4 & 5- Eluted fraction in 100 and 200 mM 
imidazole fractions, Lane 6-Purified rVP28P eluted in 250 mM imidazole. 
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Figure 2 
 
2(a) Western blot for the confirmation of expression and purification of rVP28P. Protein 
resolved in 12% SDS-PAGE gel transferred onto nitrocellulose membrane. Anti-HIS monoclonal 
antibody (1:20000) was used as primary antibody. Secondary anti mouse antibody-ALP 
(1:10000) was detected using BCIP-NBT substrates. Lane 1-Protein molecular weight marker 
(kilodaltons), Lane 2-rVP28P expressed in E. coli BL21, Lane 3-rVP28P purified by 
immobilised metal affinity chromatography. 2(b) Expression of WSSV gene vp28 in the rVP28P 
administered P. monodon juveniles compared with the PBS administered group as control. 
Animals were collected at different time points (2, 5 and 8 day) post challenge and vp28 
transcripts were assessed by semi-quantitative RT-PCR. The expression level in the PBS and 
rVP28P administered animals were calculated as the mean of the average integrated density 
values (IDV) of the amplicons relative to the expression reference gene (EF-5A). (* indicates the 
level of significance; *-p ≤ 0.05, **- p ≤ 0.01 & ***- p ≤ 0.001). 
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Figure 3 
 
Fig. 3) Expression of immune related genes a) Caspase, b) Crustin, c) Penaeidin, d) Astakine, e) 
Syntenin and f) PmRACK in rVP28P administered animals compared with the PBS administered 
group as control on 2nd, 5th and 8th days post administration (dpa) as assessed by semi-
quantitative RT-PCR. The expression level was calculated as mean of the average integrated 
density values (IDV) of the amplicons relative to the expression of reference gene (EF-5A) in the 
Y-axis and the data are expressed as mean ± SD of three individual animals. (* indicates the 
level of significance; *-p ≤ 0.05, **- p ≤ 0.01 & ***- p ≤ 0.001). 
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Figure 4 
 
Fig. 4) Expression levels of immune related genes a) Rab7, b) STAT, c) TLR and d) C-type 
lectin in rVP28P administered animals compared with the PBS administered group as control on 
2nd, 5th and 8th days post administration (dpa) as assessed by semi-quantitative RT- PCR. The 
expression level was calculated as mean of the average integrated density values (IDV) of the 
amplicons relative to the expression of reference gene (EF-5A) in the Y-axis and the data are 
expressed as mean ± SD of three individual animals. (* indicates the level of significance; *- p ≤ 
0.05, **- p ≤ 0.01 & ***- p ≤ 0.001). 
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Figure 5 
 
 
Fig.5) Time-mortality relationship of animals administered with rVP28P after WSSV challenge. 
Cumulative mortality rates of the P. monodon juveniles from the experimental groups, rVP28P 
administered and challenged as test (VP28), PBS administered and challenged as positive control 
(positive) and unvaccinated unchallenged as negative control (negative) are plotted against day 
post challenge. Each experimental group has 3 tanks with 125 animals in each as indicated in the 
Table 1. 
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Highlights 
• WSSV recombinant envelope protein VP28 was produced as truncated protein and its 
immune modulatory effects were assessed at molecular level.  
 
• Purified rVP28P was formulated as oral vaccine and administered to shrimp juveniles. 
 
• Up-regulation of syntenin caspase, penaeidin, crustin, astakine, syntenin, PmRACK, 
Rab7, STAT and C-type lectin after the administration of rVP28P points to the ability of 
rVP28P to modulate the shrimp immune system.  
 
• Lesser expression of WSSV gene vp28 in the protein administered animals and delayed 
mortality of animals in the subsequent viral challenge reveals the efficacy of rVP28P as a 
vaccine. 
 
 
 
